A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

NCT06179446 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Grippe
Influenza
Vaccines

Interventions

BIOLOGICAL: pdmFlu vaccine
BIOLOGICAL: Placebo
BIOLOGICAL: Licensed influenza vaccine

Sponsor

Pfizer